Results 41 to 50 of about 290 (122)

Recent Changes in Drug Abuse Scenario: The Novel Psychoactive Substances (NPS) Phenomenon [PDF]

open access: yes, 2019
copyright 2019 by the authors. Articles in this book are Open Access and distributed under the Creative Commons Attribution (CC BY) license, which allows users to download, copy and build upon published articles, as long as the author and publisher are ...
Catalani, Valeria   +7 more
core   +3 more sources

Сравнительный анализ экспериментальной фармакокинетики новых нейротропных пептидных лекарственных средств [PDF]

open access: yes, 2019
Experimental pharmacokinetics of new pharmacologically active peptides, modified analogues of endogenous neuropeptides, has been investigated in rats and rabbits. The study icluded 3 new drugs: (i) the nootropic drug noopept (phenylacetyl-prolyl-glycine
Boyko, S.S.   +3 more
core   +2 more sources

Effects of noopept on cognitive functions and pubertal process in rats with diabetes

open access: yesLife Sciences, 2019
Type 1 diabetes (T1DM) is a common chronic disease in childhood. Increasing insulin resistance in puberty gives rise to higher doses of insulin usage in treatment. Of this reason new approaches in treatment are needed. Noopept researches suggest it to have anti-diabetic properties.
Perihan Gürbüz   +8 more
openaire   +3 more sources

NOOTROPICS AGENTS: PHARMACEUTICAL ASPECT, COMMON EXAMPLES AND THEIR APPLICATIONS [PDF]

open access: yes, 2018
Nootropics compounds are one of the important categories of medicinal agents act as cognitive enhancers and neuroprotective. These agents mainly used to improve memory related functioning of brain.
Vitthalrao, Leena Sakhare
core   +2 more sources

Применение иммуногистохимического метода оценки цитопротективного действия антидиабетических препаратов [PDF]

open access: yes, 2017
Resume. The article describes the experience of using the immunohistochemical method of analysis with anti-insulin monoclonal antibodies to assess the cytoprotective effect of lithium salts (carbonate and chloride) on pancreatic p-cells.
S. V. Ivanov   +1 more
core   +4 more sources

Autophagy in health and disease [PDF]

open access: yes, 2017
In our lab in Sabanci University, Istanbul, we focus on signaling events regulating mammalian autophagy in health and disease. To discover new autophagy regulators and coordinators, we performed several unbiased functional screens.
Gözüaçık, Devrim
core   +1 more source

Cognitive enhancers derived from edible crops [PDF]

open access: yes, 2020
The concept of an effective cognitive boosting nootropic supplement is gaining traction with consumers, neuroscientists and regulators alike and it is therefore unsurprising that scientifically validated Nootropics are highly prized.
Chapman, Natalie, Fisk, Ian
core   +1 more source

The newest cathinone derivatives as designer drugs : an analytical and toxicological review [PDF]

open access: yes, 2018
Purpose: Currently, among new psychoactive substances, cathinone derivatives constitute the biggest group, which are mainly classified into N-alkylated, 3,4-methylenedioxy-N-alkylated, N-pyrrolidinyl, and 3,4-methylenedioxy-N-pyrrolidinyl derivatives ...
Celiński, Rafał   +4 more
core   +1 more source

Клиническая фармакокинетика ноопепта у больных с интеллектуально-мнестическими расстройствами [PDF]

open access: yes, 2005
Ноопепт — этиловый эфир фенилацетил-L-пролилглицина — пептидный аналог пирацетама разработан в ГУ НИИ фармакологии им. В. В. Закусова РАМН, в настоящее время находится на завершающем этапе клинического изучения.
В. П. Жердев,   +6 more
core   +3 more sources

Cognitive enhancing supplements and medications in United States Resident Physicians. [PDF]

open access: yesBMC Med Educ, 2022
Etheridge T   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy